In both, the bispecific and IgG1‐format BAR‐bodies, the BCR‐binding epitope of Ars2 replaces the antigen‐binding variable regions of a regular antibody to form the BAR region representing their targeting moiety to direct them to lymphoma cell BCRs. The gene discussed is SRRT; the disease is lymphoma.